Intelligence Platform

Patents

Browse 248 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 7968117

Externally triggered microcapsules

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7922999

Administration of growth factors for the treatment of CNS disorders

The Regents of the University of California · Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7867974

Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855176

Reduced volume formulation of glatiramer acetate and methods of administration

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855190

Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen ad

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807164

Lyophilized VEGF antagonist formulations for intravitreal administration

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7807645

Method of treating degenerative disorders of the nervous system by administration of fibri

The Regents of the University of California · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7771729

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant adm

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7700547

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7632510

Methods of inducing flavivirus immune responses through the administration of recombinant

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7608261

VEGF antagonist formulations suitable for intravitreal administration

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7601114

Apparatus and method for enhancing tissue repair in mammals

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534859

Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administrat

The Regents of the University of California · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531500

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7431931

Compositions and method for preventing reactogenicity associated with administration of im

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7427598

Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides f

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7387792

Pharmaceutical composition for compressed annular tablet with molded triturate tablet for

Collegium Pharmaceutical, Inc. · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7358222

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7354894

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7335640

Administration of hypocretin-1 for treatment of narcolepsy

The Regents of the University of California · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7303748

Method of treating eye injury with local administration of a VEGF inhibitor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7220757

Compositions and methods for topical administration of 2-NH-heteroarylimidazoles

Replidyne, Inc. · Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7198947

Production of functional proteins: balance of shear stress and gravity

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7179217

Apparatus for enhancing tissue repair in mammals

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)